The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests. Next-generation sequencing tests review a person’s DNA to diagnose ...
Randomized Phase III Trial for Evaluating the Efficacy of Adjuvant Abemaciclib in Patients With Locoregional Recurrence of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results